ARCS Weekly Wrap 17 October 2025

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a1/cc/9a/a1cc9a9e-a4bc-39aa-92d3-3cf6d0ab2b14/mza_15551501372172170772.jpg/600x600bb.jpg

Cognitio

ARCS Australia

35 episodes

1 day ago

Welcome to Cognitio, the weekly podcast by ARCS Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, CEO of ARCS, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve. Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

Medicine

Health & Fitness

RSS

All content for Cognitio is the property of ARCS Australia and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43238377/43238377-1741754321693-fbfa5331b1537.jpg

ARCS Weekly Wrap 17 October 2025

Cognitio

6 minutes 46 seconds

1 month ago

ARCS Weekly Wrap 17 October 2025

In this week’s ARCS Weekly News Wrap, Tim Boyle returns from Adelaide after the KCA Conference to bring you the top stories shaping Australia’s life sciences sector.

This episode covers:
• Pharma: FDA approval for MSD’s subcutaneous Keytruda, Eli Lilly’s oral obesity drug heading to the TGA, and J&J’s Stelara patent challenge.
• Medtech: AI-assisted diagnostics at Macquarie University and Optain Health’s new Melbourne research hub.
• Biotech and Investment: Momentum from Clarity Pharmaceuticals, Telix, and Chimeric Therapeutics as local innovation continues to accelerate.
• People Movement: Leadership changes across Novartis, Boehringer Ingelheim, and Boston Scientific.

Tim also reminds listeners that early bird pricing for the ARCS Clinical Summit closes 20 October and that places are still available for the upcoming Pharmacovigilance Inspections course.

Stay informed, stay connected, and join the conversation with ARCS Australia – the professional home for Australia’s medtech and pharmaceutical sector.

#ARCSAus #Pharma #Medtech #Biotech #LifeSciences #ClinicalResearch #ARCSWeeklyNewsWrap